.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Fuji
Novartis
AstraZeneca
Chinese Patent Office
Julphar
Accenture
Moodys
McKinsey
Fish and Richardson

Generated: July 24, 2017

DrugPatentWatch Database Preview

LANORINAL Drug Profile

« Back to Dashboard

What is the patent landscape for Lanorinal, and when can generic versions of Lanorinal launch?

Lanorinal is a drug marketed by Lannett and is included in two NDAs.

The generic ingredient in LANORINAL is aspirin; butalbital; caffeine. There are twenty-one drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine profile page.

Summary for Tradename: LANORINAL

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list76
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LANORINAL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett
LANORINAL
aspirin; butalbital; caffeine
TABLET;ORAL086986-002Oct 18, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett
LANORINAL
aspirin; butalbital; caffeine
CAPSULE;ORAL086996-002Oct 11, 1985AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Accenture
Baxter
Daiichi Sankyo
Julphar
Fuji
Boehringer Ingelheim
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot